142 related articles for article (PubMed ID: 22218301)
1. Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins.
Enkirch T; Kneissl S; Hoyler B; Ungerechts G; Stremmel W; Buchholz CJ; Springfeld C
Gene Ther; 2013 Jan; 20(1):16-23. PubMed ID: 22218301
[TBL] [Abstract][Full Text] [Related]
2. Envelope targeting: hemagglutinin attachment specificity rather than fusion protein cleavage-activation restricts Tupaia paramyxovirus tropism.
Springfeld C; von Messling V; Tidona CA; Darai G; Cattaneo R
J Virol; 2005 Aug; 79(16):10155-63. PubMed ID: 16051808
[TBL] [Abstract][Full Text] [Related]
3. Targeted cell entry of lentiviral vectors.
Funke S; Maisner A; Mühlebach MD; Koehl U; Grez M; Cattaneo R; Cichutek K; Buchholz CJ
Mol Ther; 2008 Aug; 16(8):1427-36. PubMed ID: 18578012
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.
Lévy C; Amirache F; Costa C; Frecha C; Muller CP; Kweder H; Buckland R; Cosset FL; Verhoeyen E
Mol Ther; 2012 Sep; 20(9):1699-712. PubMed ID: 22617109
[TBL] [Abstract][Full Text] [Related]
5. Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins.
Hudacek AW; Navaratnarajah CK; Cattaneo R
Cancer Gene Ther; 2013 Feb; 20(2):109-16. PubMed ID: 23306608
[TBL] [Abstract][Full Text] [Related]
6. A Tupaia paramyxovirus vector system for targeting and transgene expression.
Engeland CE; Bossow S; Hudacek AW; Hoyler B; Förster J; Veinalde R; Jäger D; Cattaneo R; Ungerechts G; Springfeld C
J Gen Virol; 2017 Sep; 98(9):2248-2257. PubMed ID: 28809150
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
[TBL] [Abstract][Full Text] [Related]
8.
Argaw T; Marino MP; Timmons A; Eldridge L; Takeda K; Li P; Kwilas A; Ou W; Reiser J
Mol Ther Methods Clin Dev; 2021 Jun; 21():670-680. PubMed ID: 34141822
[TBL] [Abstract][Full Text] [Related]
9. Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.
Kneissl S; Abel T; Rasbach A; Brynza J; Schneider-Schaulies J; Buchholz CJ
PLoS One; 2012; 7(10):e46667. PubMed ID: 23071609
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vectors pseudotyped with envelope glycoproteins derived from human parainfluenza virus type 3.
Jung C; Grzybowski BN; Tong S; Cheng L; Compans RW; Le Doux JM
Biotechnol Prog; 2004; 20(6):1810-6. PubMed ID: 15575716
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro.
Schauber CA; Tuerk MJ; Pacheco CD; Escarpe PA; Veres G
Gene Ther; 2004 Feb; 11(3):266-75. PubMed ID: 14737086
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions.
Kahl CA; Pollok K; Haneline LS; Cornetta K
Mol Ther; 2005 Mar; 11(3):470-82. PubMed ID: 15727944
[TBL] [Abstract][Full Text] [Related]
13. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
[TBL] [Abstract][Full Text] [Related]
14. Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors.
Frecha C; Lévy C; Costa C; Nègre D; Amirache F; Buckland R; Russell SJ; Cosset FL; Verhoeyen E
J Virol; 2011 Jun; 85(12):5975-85. PubMed ID: 21450813
[TBL] [Abstract][Full Text] [Related]
15. Gene delivery to airway epithelial cells in vivo: a direct comparison of apical and basolateral transduction strategies using pseudotyped lentivirus vectors.
Kremer KL; Dunning KR; Parsons DW; Anson DS
J Gene Med; 2007 May; 9(5):362-8. PubMed ID: 17380490
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral vectors with measles virus glycoproteins - dream team for gene transfer?
Buchholz CJ; Mühlebach MD; Cichutek K
Trends Biotechnol; 2009 May; 27(5):259-65. PubMed ID: 19327858
[TBL] [Abstract][Full Text] [Related]
17. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC
Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505
[TBL] [Abstract][Full Text] [Related]
18. Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity.
Funke S; Schneider IC; Glaser S; Mühlebach MD; Moritz T; Cattaneo R; Cichutek K; Buchholz CJ
Gene Ther; 2009 May; 16(5):700-5. PubMed ID: 19212424
[TBL] [Abstract][Full Text] [Related]
19. Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies.
Aires da Silva F; Costa MJ; Corte-Real S; Goncalves J
Hum Gene Ther; 2005 Feb; 16(2):223-34. PubMed ID: 15761262
[TBL] [Abstract][Full Text] [Related]
20. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.
Kumar M; Bradow BP; Zimmerberg J
Hum Gene Ther; 2003 Jan; 14(1):67-77. PubMed ID: 12573060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
